Cargando…

Antiseptic 9-Meric Peptide with Potency against Carbapenem-Resistant Acinetobacter baumannii Infection

Carbapenem-resistant A. baumannii (CRAB) infection can cause acute host reactions that lead to high-fatality sepsis, making it important to develop new therapeutic options. Previously, we developed a short 9-meric peptide, Pro9-3D, with significant antibacterial and cytotoxic effects. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishnan, Manigandan, Choi, Joonhyeok, Jang, Ahjin, Yoon, Young Kyung, Kim, Yangmee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621208/ https://www.ncbi.nlm.nih.gov/pubmed/34830401 http://dx.doi.org/10.3390/ijms222212520

Ejemplares similares

Anti-Endotoxin 9-Meric Peptide with Therapeutic Potential for the Treatment of Endotoxemia
por: Krishnan, Manigandan, et al.
Publicado: (2021)

Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Infection
por: Choi, Joonhyeok, et al.
Publicado: (2021)

A Novel Peptide Antibiotic, Pro10-1D, Designed from Insect Defensin Shows Antibacterial and Anti-Inflammatory Activities in Sepsis Models
por: Krishnan, Manigandan, et al.
Publicado: (2020)

Rhamnetin, a Natural Flavonoid, Ameliorates Organ Damage in a Mouse Model of Carbapenem-Resistant Acinetobacter baumannii-Induced Sepsis
por: Lee, Hyeju, et al.
Publicado: (2022)

Molecular mechanism underlying the TLR4 antagonistic and antiseptic activities of papiliocin, an insect innate immune response molecule
por: Krishnan, Manigandan, et al.
Publicado: (2022)

Structural comparison of Acinetobacter baumannii β-ketoacyl-acyl carrier protein reductases in fatty acid and aryl polyene biosynthesis
por: Lee, Woo Cheol, et al.
Publicado: (2021)

Deciphering the Binding Interactions between Acinetobacter baumannii ACP and β-ketoacyl ACP Synthase III to Improve Antibiotic Targeting Using NMR Spectroscopy
por: Choi, Sungjae, et al.
Publicado: (2021)

Protective Effects of Rhamnetin in Carbapenem-Resistant Acinetobacter baumannii-Induced Sepsis Model and the Underlying Mechanism
por: Kim, Minju, et al.
Publicado: (2023)

Development of a novel short 12-meric papiliocin-derived peptide that is effective against Gram-negative sepsis
por: Kim, Jieun, et al.
Publicado: (2019)

Clinical impact of COVID-19 in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia
por: Kim, Jeong Yeon, et al.
Publicado: (2023)

Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship
por: Yoon, Young Kyung, et al.
Publicado: (2014)

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2014)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
por: Takagi, E.H., et al.
Publicado: (2009)

Fanny pack transmission of carbapenem-resistant Acinetobacter baumannii
por: DelleFave, Amber, et al.
Publicado: (2023)

Molecular and virulence characteristics of carbapenem-resistant Acinetobacter baumannii isolates: a prospective cohort study
por: Park, Seung Min, et al.
Publicado: (2023)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Nosocomial Outbreak of Carbapenem-Resistant Acinetobacter baumannii in Intensive Care Units and Successful Outbreak Control Program
por: Choi, Won Suk, et al.
Publicado: (2010)

Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii
por: Nagarajan, Deepesh, et al.
Publicado: (2019)

Antimicrobial Peptide Cec4 Eradicates the Bacteria of Clinical Carbapenem-Resistant Acinetobacter baumannii Biofilm
por: Liu, Weiwei, et al.
Publicado: (2020)

Molecular Epidemiology of Carbapenem Non-Susceptible Acinetobacter baumannii in France
por: Jeannot, Katy, et al.
Publicado: (2014)

Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii
por: Pagano, Mariana, et al.
Publicado: (2016)

Seasonal Occurrence and Carbapenem Susceptibility of Bovine Acinetobacter baumannii in Germany
por: Klotz, Peter, et al.
Publicado: (2019)

Heterocyclic Diaryliodonium-Based Inhibitors of Carbapenem-Resistant Acinetobacter baumannii
por: Kumari, Pooja, et al.
Publicado: (2023)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Park, Jae-Min, et al.
Publicado: (2021)

O047: The effect of active surveillance culture of carbapenem resistant Acinetobacter baumannii on the occurrence of carbapenem resistant Acinetobacter baumannii bacteremia in a single intensive care unit
por: Kim, G, et al.
Publicado: (2013)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii
por: Vashist, Jitendra, et al.
Publicado: (2011)

Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid
por: Nigro, Steven J., et al.
Publicado: (2015)

Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran
por: Farshadzadeh, Zahra, et al.
Publicado: (2015)

Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland
por: Ramette, A., et al.
Publicado: (2018)

Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection
por: Hawkey, Jane, et al.
Publicado: (2018)

Is Aerosalization a Problem With Carbapenem-Resistant Acinetobacter baumannii in Thailand Hospital?
por: Apisarnthanarak, Anucha, et al.
Publicado: (2016)

Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections
por: Park, Sang-Won
Publicado: (2019)

Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii
por: Hamidian, Mohammad, et al.
Publicado: (2019)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant Acinetobacter baumannii
por: Yang, Tsung-Ying, et al.
Publicado: (2021)

Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolates from Clinical Specimens
por: Abdullah, Khansaa, et al.
Publicado: (2021)

Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?
por: Gontijo, Aline Vidal Lacerda, et al.
Publicado: (2021)

Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
por: Bartal, Carmi, et al.
Publicado: (2022)

Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit
por: Jiang, Yuan, et al.
Publicado: (2022)

Characterisation of pellicle-forming ability in clinical carbapenem-resistant Acinetobacter baumannii
por: Ng, Heng Kang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dr3d4nc2uldld8c83tf04o97ld